Biofil Chemicals & Pharmaceuticals Ltd. announced it has entered into a sale agreement to dispose of its entire undertaking for INR 4.12 Crore, which contributed 69.61% to its total turnover and 64.81% to its net worth in the last financial year; the transaction with Cyano Pharma Pvt Ltd is classified as a related party transaction, expected to be completed by March 31, 2025, pending shareholder approval.